Difference between revisions of "Part:BBa K1041002"
(→Sequencing) |
|||
Line 2: | Line 2: | ||
<partinfo>BBa_K1041002 short</partinfo> | <partinfo>BBa_K1041002 short</partinfo> | ||
− | Team NRP-UEA_Norwich 2013 created this part using biobricks <partinfo>BBa_K1041000</partinfo> and <partinfo>BBa_K1041001</partinfo>. These biobricks both contain | + | Team NRP-UEA_Norwich 2013 created this part using biobricks <partinfo>BBa_K1041000</partinfo> and <partinfo>BBa_K1041001</partinfo>. These biobricks both contain an Nde1 site after their promoter sequence, enabling a restriction digest to be performed. The RFP coding gene was excised from BBa_K1041000 and ligated downstream of the AntG promoter of BBa_K1041001 to create this new biobrick. |
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here | ||
Line 20: | Line 20: | ||
===Restriction Digest=== | ===Restriction Digest=== | ||
− | Part Bba_K1041002 was digested with enzyme NdeI and compared to uncut DNA ''Fig 1 | + | Part Bba_K1041002 was digested with enzyme NdeI and compared to uncut DNA (''Fig 1''). The enzyme digest shows the NdeI restriction has been conserved after ligation of fragments from parts Bba_J04450 and Bba_K1041001. |
− | [[image:BIORAD 2013-09-18 16hr 02min 2.JPG|thumb|left|Fig 1:Lane 1 contains and Bba_K1041002 cut with NdeI and lane 2 uncut Bba_K1041002.]] | + | [[image:BIORAD 2013-09-18 16hr 02min 2.JPG|thumb|left|Fig 1: Lane 1 contains and Bba_K1041002 cut with NdeI and lane 2 uncut Bba_K1041002.]] |
<br> | <br> | ||
Line 43: | Line 43: | ||
===Sequencing=== | ===Sequencing=== | ||
− | The biobrick was sent off to a company for sequencing and the data | + | The biobrick was sent off to a company for sequencing and the data received showed the DNA was good quality as strong chromatographic peaks were produced throughout analysis of the sample (''Figs 2,3,4''). |
[[image:K1041002 1.JPG|thumb|left|Fig 2:K1041002 sequencing data part 1]] | [[image:K1041002 1.JPG|thumb|left|Fig 2:K1041002 sequencing data part 1]] | ||
Line 60: | Line 60: | ||
===BLAST Analysis=== | ===BLAST Analysis=== | ||
− | The data we | + | The data we received back from the sequencing company was aligned using BLAST with the expected DNA sequence (''Figs 5,6'').The sequencing with both the forward and reverse primers had over 96% matches. Deviations from the expected sequence were at the end of the useful sequencing data and combination of both sets of data confirmed a complete match with the expected sequence. |
[[image:6 Fwd.JPG|thumb|left|Fig 5: Forward primer K1041002 sequencing data aligned with the expected DNA sequence]] | [[image:6 Fwd.JPG|thumb|left|Fig 5: Forward primer K1041002 sequencing data aligned with the expected DNA sequence]] | ||
[[image:6 Rev.JPG|thumb|left|Fig 6: Reverse primer K1041002 sequencing data aligned with the expected DNA sequence]] | [[image:6 Rev.JPG|thumb|left|Fig 6: Reverse primer K1041002 sequencing data aligned with the expected DNA sequence]] |
Latest revision as of 22:13, 4 October 2013
AntG Promoter + RFP Coding Device
Team NRP-UEA_Norwich 2013 created this part using biobricks BBa_K1041000 and BBa_K1041001. These biobricks both contain an Nde1 site after their promoter sequence, enabling a restriction digest to be performed. The RFP coding gene was excised from BBa_K1041000 and ligated downstream of the AntG promoter of BBa_K1041001 to create this new biobrick.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal AgeI site found at 683
Illegal AgeI site found at 795 - 1000COMPATIBLE WITH RFC[1000]
Characterisation
Characterisation of this biobrick involved sequencing, restriction digests and BLAST analysis.
Restriction Digest
Part Bba_K1041002 was digested with enzyme NdeI and compared to uncut DNA (Fig 1). The enzyme digest shows the NdeI restriction has been conserved after ligation of fragments from parts Bba_J04450 and Bba_K1041001.
Sequencing
The biobrick was sent off to a company for sequencing and the data received showed the DNA was good quality as strong chromatographic peaks were produced throughout analysis of the sample (Figs 2,3,4).
BLAST Analysis
The data we received back from the sequencing company was aligned using BLAST with the expected DNA sequence (Figs 5,6).The sequencing with both the forward and reverse primers had over 96% matches. Deviations from the expected sequence were at the end of the useful sequencing data and combination of both sets of data confirmed a complete match with the expected sequence.